Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlotta Boscaro

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|April 30, 2021
Estrogen Receptor Functions and Pathways at the Vascular Immune InterfaceAida Dama, Chiara Baggio, Carlotta Boscaro, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2023
Post-Transcriptional and Epigenetic Regulation of Estrogen SignalingAndrea Cignarella, Carlotta Boscaro, Mattia Albiero, et al.
Life Sciences|October 1, 2023
MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPERCarlotta Boscaro, Giovanni Eugenio Ramaschi, Lucia Trevisi, et al.
International Journal of Molecular Sciences|March 16, 2018
Estrogen, Angiogenesis, Immunity and Cell Metabolism: Solving the PuzzleAnnalisa Trenti, Serena Tedesco, Carlotta Boscaro, et al.
Biochemical Pharmacology|June 12, 2018
Effects of digitoxin on cell migration in ovarian cancer inflammatory microenvironmentAnnalisa Trenti, Carlotta Boscaro, Serena Tedesco, et al.
Biochemical Pharmacology|February 11, 2024
The antiangiogenic effect of digitoxin is dependent on a ROS-elicited RhoA/ROCK pathway activationCarlotta Boscaro, Gudula Schimdt, Andrea Cignarella, et al.
Diabetes, Obesity & Metabolism|May 10, 2026
Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal TolerabilityGian Paolo Fadini, Mario Luca Morieri, Carlotta Boscaro, et al.
Frontiers in Pharmacology|January 4, 2021
Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK ActivationCarlotta Boscaro, Annalisa Trenti, Chiara Baggio, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 2, 2022
Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulationCarlotta Boscaro, Chiara Baggio, Marcello Carotti, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2017
The Glycolytic Enzyme PFKFB3 Is Involved in Estrogen-Mediated Angiogenesis via GPER1Annalisa Trenti, Serena Tedesco, Carlotta Boscaro, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|April 30, 2021
Estrogen Receptor Functions and Pathways at the Vascular Immune InterfaceAida Dama, Chiara Baggio, Carlotta Boscaro, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2023
Post-Transcriptional and Epigenetic Regulation of Estrogen SignalingAndrea Cignarella, Carlotta Boscaro, Mattia Albiero, et al.
Life Sciences|October 1, 2023
MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPERCarlotta Boscaro, Giovanni Eugenio Ramaschi, Lucia Trevisi, et al.
International Journal of Molecular Sciences|March 16, 2018
Estrogen, Angiogenesis, Immunity and Cell Metabolism: Solving the PuzzleAnnalisa Trenti, Serena Tedesco, Carlotta Boscaro, et al.
Biochemical Pharmacology|June 12, 2018
Effects of digitoxin on cell migration in ovarian cancer inflammatory microenvironmentAnnalisa Trenti, Carlotta Boscaro, Serena Tedesco, et al.
Biochemical Pharmacology|February 11, 2024
The antiangiogenic effect of digitoxin is dependent on a ROS-elicited RhoA/ROCK pathway activationCarlotta Boscaro, Gudula Schimdt, Andrea Cignarella, et al.
Diabetes, Obesity & Metabolism|May 10, 2026
Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal TolerabilityGian Paolo Fadini, Mario Luca Morieri, Carlotta Boscaro, et al.
Frontiers in Pharmacology|January 4, 2021
Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK ActivationCarlotta Boscaro, Annalisa Trenti, Chiara Baggio, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 2, 2022
Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulationCarlotta Boscaro, Chiara Baggio, Marcello Carotti, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2017
The Glycolytic Enzyme PFKFB3 Is Involved in Estrogen-Mediated Angiogenesis via GPER1Annalisa Trenti, Serena Tedesco, Carlotta Boscaro, et al.
Pageof 2